Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

864 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network.
Del Principe MI, Buzzatti E, Piciocchi A, Forghieri F, Bonifacio M, Lessi F, Imbergamo S, Orciuolo E, Rossi G, Fracchiolla N, Trappolini S, Neri B, Sarlo C, Zappasodi P, Dargenio M, Cefalo M, Irno-Consalvo MA, Conti C, Paterno G, De Angelis G, Sciumè M, Della Starza I, Venditti A, Foà R, Guarini AR. Del Principe MI, et al. Among authors: de angelis g. Haematologica. 2021 Jan 1;106(1):39-45. doi: 10.3324/haematol.2019.231704. Haematologica. 2021. PMID: 31879328 Free PMC article.
High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma.
Del Principe MI, Buccisano F, Cefalo M, Maurillo L, Di Caprio L, Di Piazza F, Sarlo C, De Angelis G, Irno Consalvo M, Fraboni D, De Santis G, Ditto C, Postorino M, Sconocchia G, Del Poeta G, Amadori S, Venditti A. Del Principe MI, et al. Among authors: de angelis g, de santis g. Ann Hematol. 2014 Sep;93(9):1509-13. doi: 10.1007/s00277-014-2080-6. Epub 2014 Apr 22. Ann Hematol. 2014. PMID: 24752416
Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia.
Maurillo L, Buccisano F, Piciocchi A, Del Principe MI, Sarlo C, Di Veroli A, Panetta P, Irno-Consalvo M, Nasso D, Ditto C, Refrigeri M, De Angelis G, Cerretti R, Arcese W, Sconocchia G, Lo-Coco F, Amadori S, Venditti A. Maurillo L, et al. Among authors: de angelis g. Am J Hematol. 2015 Feb;90(2):125-31. doi: 10.1002/ajh.23893. Epub 2014 Nov 24. Am J Hematol. 2015. PMID: 25377359 Free article. Clinical Trial.
Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome.
Del Principe MI, Buccisano F, Soddu S, Maurillo L, Cefalo M, Piciocchi A, Consalvo MI, Paterno G, Sarlo C, De Bellis E, Zizzari A, De Angelis G, Fraboni D, Divona M, Voso MT, Sconocchia G, Del Poeta G, Lo-Coco F, Arcese W, Amadori S, Venditti A. Del Principe MI, et al. Among authors: de bellis e, de angelis g. Semin Hematol. 2018 Oct;55(4):209-214. doi: 10.1053/j.seminhematol.2018.02.006. Epub 2018 Feb 21. Semin Hematol. 2018. PMID: 30502849 Review.
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation.
Buccisano F, Palmieri R, Piciocchi A, Maurillo L, Del Principe MI, Paterno G, Soddu S, Cerretti R, De Angelis G, Mariotti B, Irno Consalvo MA, Conti C, Fraboni D, Divona M, Ottone T, Lavorgna S, Panetta P, Voso MT, Arcese W, Venditti A. Buccisano F, et al. Among authors: de angelis g. Cancers (Basel). 2021 Mar 3;13(5):1083. doi: 10.3390/cancers13051083. Cancers (Basel). 2021. PMID: 33802502 Free PMC article.
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML.
Travaglini S, Ottone T, Angelini DF, Fiori V, Dominici S, Noguera NI, Śniegocka M, Antonelli S, Irno Consalvo MA, De Bardi M, Banella C, Divona M, Marchesi F, Masciarelli S, Fazi F, Pieraccioli M, Palmieri R, De Angelis G, Buccisano F, Venditti A, Battistini L, Magnani M, Voso MT. Travaglini S, et al. Among authors: de bardi m, de angelis g. Leukemia. 2022 Jun;36(6):1685-1688. doi: 10.1038/s41375-022-01566-5. Epub 2022 Apr 14. Leukemia. 2022. PMID: 35422094 No abstract available.
Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation.
Trotta GE, Ciangola G, Cerroni I, Mezzanotte V, Nunzi A, Anemona L, Savino L, De Angelis G, Mariotti B, Bonanni F, Meddi E, Zizzari A, Rapisarda VM, Mangione I, Bruno A, Cantonetti M, Venditti A, Cerretti R. Trotta GE, et al. Among authors: de angelis g. Curr Res Transl Med. 2024 Sep;72(3):103452. doi: 10.1016/j.retram.2024.103452. Epub 2024 Apr 24. Curr Res Transl Med. 2024. PMID: 38718540
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant.
Renzi D, Marchesi F, De Angelis G, Elia L, Salvatorelli E, Gumenyuk S, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Arcese W, Mengarelli A; Rome Transplant Network. Renzi D, et al. Among authors: de angelis g. Chemotherapy. 2017;62(1):58-61. doi: 10.1159/000448750. Epub 2016 Sep 10. Chemotherapy. 2017. PMID: 27618144
Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare T-cell lymphoma: A clinical challenge.
Nunzi A, Ciangola G, Cerroni I, Mezzanotte V, Trotta GE, Meconi F, Zizzari A, Rapisarda VM, Savino L, Brega A, Argirò R, De Angelis G, Mariotti B, Bonanni F, Meddi E, Gurnari C, Bruno A, Mangione I, Venditti A, Cerretti R. Nunzi A, et al. Among authors: de angelis g. Curr Res Transl Med. 2024 Jun;72(2):103436. doi: 10.1016/j.retram.2023.103436. Epub 2023 Dec 20. Curr Res Transl Med. 2024. PMID: 38277899
864 results